Ann: Request for Extension of Voluntary Suspension, page-10

@Neil1959 Unfortunately Canntab is restructuring as well by the looks of things. If your going to the AGM one of the questions you might consider is if there is a possibility of CGB producing Canntab in Thailand for distribution to agreed licensed countries such as Australia Japan India Korea for example. A lot of global pharma companies use Thailand as a manufacturing base for Asia distribution.

It looks like it might be a while before we see any product in Australia, Im taking Canntab out of my asset allocation for CGB for the time being until we get some positive news. its a shame we all had such high hopes for it, it is a great product in theory.